Protocol Information

If you are interested in learning more about this study, please call or email the contact person below

Title A Phase 3 Study to Evaluate the Glucose Response of G-Pen (Glucagon Injection) in Pediatric Patients with Type 1 Diabetes
Description Glucose Response of G-Pen (Glucagon Injection) in Children with Type 1 Diabetes

Study visits will be at Children's Hospital
Objective This is a sequential efficacy and safety study in pediatric patients with type 1 diabetes. Subjects will be administered insulin to induce a low normal glycemic state and will then receive an age-appropriate dose of G-Pen™ (glucagon injection) in a clinical research center (CRC) or comparable setting.
Principal Investigator BETHIN, KATHLEEN
Age Group Children
Drugs Involved
Status Open
Key Eligibility Children ages 2-17
Type I Diabetes
Disease Group Children's Health/Pediatrics; Diabetes; Endocrine Diseases
Treatment Glucagon Injection (G-Pen)
Contact Emily Gorman